Type 1 Diabetes Extension Study
Public ClinicalTrials.gov record NCT02734277. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D). This observational study will: * follow participants to determine how long they continue to produce insulin, and * will also assess how changes in the immune system over time relate to the ability to produce insulin. This information could help design better therapies for type 1 diabetes in the future.
Study identification
- NCT ID
- NCT02734277
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 111 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 8 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 8, 2016 (Actual)
- Primary completion
- Aug 2028 (Estimated)
- Completion
- Aug 2028 (Estimated)
- Last update posted
- Sep 18, 2026
2016 – 2028
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSF School of Medicine | San Francisco | California | 94143 | Recruiting |
| Stanford University | Stanford | California | 94305 | Recruiting |
| University of Colorado School of Medicine: Barbara Davis Center for Diabetes | Aurora | Colorado | 80045 | Recruiting |
| Yale University | New Haven | Connecticut | 06519 | Completed |
| Emory University | Atlanta | Georgia | 30322 | Withdrawn |
| Indiana University Riley Hospital for Children | Indianapolis | Indiana | 46202 | Recruiting |
| University of Iowa Health Care Division of Pediatric Endocrinology | Iowa City | Iowa | 52242 | Recruiting |
| Joslin Diabetes Center | Boston | Massachusetts | 02215 | Recruiting |
| University of Minnesota | Minneapolis | Minnesota | 55454 | Recruiting |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | Completed |
| Sanford Research | Sioux Falls | South Dakota | 57104 | Completed |
| Benaroya Research Institute | Seattle | Washington | 98101 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02734277, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02734277 live on ClinicalTrials.gov.